Navigation Links
F1000Research articles will be listed in PubMed, and deposited in PubMed Central
Date:1/14/2013

F1000Research is F1000's new open access publishing program that offers immediate publication followed by a thorough and completely open peer review process, executed after publication. Following recent approval by the National Library of Medicine (NLM)'s Selections group, all articles that pass this peer review process will now be listed in PubMed and deposited within PubMed Central.

F1000Research's acceptance by the NLM Selections group follows agreements confirmed with Elsevier in 2012 for the indexing of F1000Research articles in Scopus and Embase.


'/>"/>

Contact: Eleanor Howell
press@f1000.com
44-020-763-19129
Faculty of 1000: Biology and Medicine
Source:Eurekalert

Page: 1

Related biology news :

1. F1000Research, the first Open Science publisher, launches following a successful beta testing phase
2. Nanoparticles reach new peaks
3. Study reports iron oxide nanoparticles effective for labeling human endothelial cells
4. Synthetic and biological nanoparticles combined to produce new metamaterials
5. Outside a vacuum: Model predicts movement of charged particles in complex media
6. Airborne particles smuggle pollutants to far reaches of globe
7. UC Davis researchers develop new drug delivery system for bladder cancer using nanoparticles
8. GEOLOGY adds 30 new articles online
9. Nanoparticles reboot blood flow in brain
10. Nanoparticles added to platelets double internal injury survival rate
11. Carnegie Mellon study shows skin-aging radicals age naturally formed particles in the air
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/11/2017)... , Jan. 11, 2017 Intoxalock, a ... with the release of its patent-pending calibration device. With ... reliably perform calibrations, securely upload data logs and process ... the customer. "Fighting drunk driving through the ... the public at large, but also for the customer ...
(Date:1/6/2017)... LA JOLLA, Calif. , Jan. 6, 2017 ... Phase 1 safety studies in healthy volunteers of ... CM4620, intended to treat acute pancreatitis. ... pancreas, is typically a mild disorder, but can ... to organ failure and sepsis, where extended hospital ...
(Date:1/6/2017)... 2017  Delta ID Inc., a leader in consumer-grade ... automotive at CESĀ® 2017. Delta ID has collaborated with ... the use of iris scanning as a secure, reliable ... in a car, and as a way to elevate ... Delta ID and Gentex will demonstrate (booth #7326 ...
Breaking Biology News(10 mins):
(Date:1/21/2017)... , Jan. 20, 2017 Bioptix, Inc. ... "Company"), announced that on January 14, 2017 the Board ... which the Company will terminate certain employees associated with ... Inc.  The Company commenced terminations on January 16, 2017 ... days.  The Company may pay severance benefits in certain ...
(Date:1/20/2017)... -- Ginkgo Bioworks, the organism company, announced today ... synthesis and assembly of DNA. The acquisition will ... DNA into Ginkgo,s automated organism engineering foundries, enabling ... new organism designs for application across a wide ... to significantly increase the world,s capacity to cost-effectively ...
(Date:1/19/2017)... LOUISVILLE, Ky. and HOUSTON ... Prenatal Inc. ("NX Prenatal") today announced the formation ... brings together leading clinicians and industry veterans who ... the company as it accelerates development of its ... positioned to provide medical, clinical and strategic guidance ...
(Date:1/19/2017)... Md. and GAITHERSBURG, Md. ... (NYSE MKT: PIP) and Altimmune, Inc., a privately-held ... signing of a definitive agreement for the merger ... Altimmune,s current investors include Novartis Venture Fund, HealthCap, ... will be a fully-integrated and diversified immunotherapeutics company ...
Breaking Biology Technology: